Pvac Medical Technologies Ltd.

Galderma S.a.

Galderma Holding Sa

Termira Ab

Kristoffer Bergman

Thomas Engstrand

Tim Bowden

Lennart Soderberg

Johan Olsson

Morgan Karlsson

Åke Öhrlund

Jons Hilborn

Dmitri Ossipov

Jöns Hilborn

Lennart SÖDERBERG

Bowden Tim

The present technology is directed to methods of producing 6,6'-diamino-6,6′-dideoxy-trehalose ('DATH') or a salt thereof. The methods include optionally protecting one or more hydroxyl groups of D-trehalose and converting the primary hydroxyl groups of D-trehalose to produce DATH or a salt thereof through use of a halogen, azide, and/or protected amine. The present technology is also directed to intermediate products of the methods.

Process for the production of DATH and intermediates thereof

A graft copolymer comprising: a core polymer comprising a crosslinked or non-crosslinked polysaccharide, a plurality of primary graft polymers covalently grafted to the core polymer, a plurality of secondary graft polymers covalently grafted to each primary graft polymer, an injectable dermal aesthetic formulation comprising such a graft copolymer and a method of preparing such a graft copolymer.

Graft copolymer

A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X(&#x2014;R&#x2033;&#x2014;)(&#x2014;R')Hwhere: a) Xis a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) &#x2014;R&#x2033;&#x2014; is a bivalent organic group providing attachment to the carrier via one of its free valences and to Xat the other free valence; and d) R&#x2032;&#x2014; is a monovalent organic group attached to the Xvia its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.

Active principle for mitigating undesired medical conditions

A composition, which upon activation, spontaneously forms a cross-linked hydrogel in aqueous liquid, includes:

Composition for the formation of gels

Growing community of inventors

Stockholm, Sweden

Kristoffer Bergman